[Acute diabetic metabolic disorders during therapy of lymphoblastic leukemias].
D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005951:Glucose Tolerance Test; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin
Akute diabetische Stoffwechselstörungen während der Behandlung lymphoblastischer Leukämien